Ewelina Woźniak

10PUBLICATIONS
17CO-AUTHORS
Preventative health carePredictive and prognostic markersMolecular medicineCardiology (incl. cardiovascular diseases)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 13, 2025
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia.

Ewelina Woźniak, Agnieszka Woźniak, Agnieszka Pawlos

|Jul 23, 2024
OxLDL as a prognostic biomarker of plaque instability in patients qualified for carotid endarterectomy.

Agnieszka Woźniak, Joanna Satała, Paulina Gorzelak-Pabiś

|Feb 11, 2023
SGLT2 Inhibitors May Restore Endothelial Barrier Interrupted by 25-Hydroxycholesterol.

Agnieszka Pawlos, Marlena Broncel, Ewelina Woźniak

|Feb 08, 2023
The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells.

Ewelina Woźniak, Marlena Broncel, Mateusz Niedzielski

|Dec 10, 2021
Neuroprotective Effect of SGLT2 Inhibitors.

Agnieszka Pawlos, Marlena Broncel, Ewelina Woźniak

|Sep 07, 2021
A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol.

Mateusz Niedzielski, Marlena Broncel, Paulina Gorzelak-Pabiś

Pageof 2

Frequent Collaborators

5 joint publications

Marlena Broncel

5 joint publications

Paulina Gorzelak-Pabiś

3 joint publications

Bożena Bukowska

3 joint publications

Agnieszka Pawlos